At Mimi-Q, we've pioneered a novel approach that revolutionizes the way pre-clinical data is handled, introducing a seamless and efficient solution for in-vitro clinical trials.
Through advanced data analysis, we pinpoint metabolic vulnerabilities in cancer cells and uncover associated biomarkers, providing crucial insights for targeted and effective therapeutic interventions.
Our pharmacological modeling empowers us to evaluate the impact of treatments in clinically-relevant setups, ensuring a comprehensive understanding of their effects for more informed and effective therapeutic strategies
Our custom-designed device facilitates high-throughput testing, empowering streamlined and efficient data generation for accelerated research and innovation.
